INSTEM PLC - ORD 10P

INSTEM PLC - ORD 10P

Aktie · GB00B3TQCK30 (XLON)
Übersicht
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu INSTEM PLC - ORD 10P
Kein Kurs
Free Float & Liquidität
Free Float 56,76 %
Shares Float 13,65 M
Ausstehende Aktien 24,05 M
Firmenprofil zu INSTEM PLC - ORD 10P Aktie
Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Logbook, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities in non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; SEND Explorer, a web-based application with optional data warehousing capabilities; SENDTrial, a web based solution that can be accessed through a subscription; and standard for exchange of nonclinical data solutions. Further, the company provides Sorcerer Colony Counter for automatic plate counter; sales support, training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; and software solutions to extract intelligence from research and development related healthcare data. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.

Unternehmensdaten

Name INSTEM PLC - ORD 10P
Firma Instem plc
Website https://www.instem.com
Heimatbörse XLON London
ISIN GB00B3TQCK30
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Phil J. Reason
Marktkapitalisierung 199 Mio
Land Großbritannien und Nordirland
Währung GBP
Mitarbeiter 0,5 T
Adresse Diamond Way, ST15 0SD Stone
IPO Datum 2010-01-12

Ticker Symbole

Name Symbol
London INS.L
Weitere Aktien
Investoren, die INSTEM PLC - ORD 10P halten, haben auch folgende Aktien im Depot:
Innovator U.S. Equity Accelerated ETF - October
Innovator U.S. Equity Accelerated ETF - October ETF
Wearable Health Solutions, Inc.
Wearable Health Solutions, Inc. Aktie